Mustang Financial Statements From 2010 to 2024

MBIO Stock  USD 0.37  0.01  2.63%   
Mustang Bio financial statements provide useful quarterly and yearly information to potential Mustang Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mustang Bio financial statements helps investors assess Mustang Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mustang Bio's valuation are summarized below:
Market Capitalization
3.9 M
Revenue
-50 K
Earnings Share
(6.00)
Revenue Per Share
(0)
We have found one hundred twenty available fundamental ratios for Mustang Bio, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Mustang Bio's last-minute fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 19th of April 2024, Market Cap is likely to drop to about 11 M. In addition to that, Enterprise Value is likely to drop to about 7.5 M
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0329 or PTB Ratio of 99.16. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
  
This module can also supplement various Mustang Bio Technical models . Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Mustang Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Short and Long Term Debt Total2.4 M2.5 M7.3 M
Slightly volatile
Total Current Liabilities9.2 M15.4 MM
Slightly volatile
Accounts Payable6.5 M6.3 MM
Slightly volatile
Common Stock Total Equity8.5 K8.1 K3.7 K
Slightly volatile
Common Stock Shares Outstanding5.3 M8.6 M6.9 M
Slightly volatile
Non Current Liabilities Total2.1 M2.2 M5.1 M
Pretty Stable
Capital Surpluse333.2 M317.4 M126.7 M
Slightly volatile
Other Stockholder Equity223.5 M380.5 M136.9 M
Slightly volatile
Total Liabilities15.5 M17.6 M10.9 M
Slightly volatile
Short and Long Term Debt1.4 M1.1 M2.1 M
Slightly volatile
Short Term Debt817.8 K520 K1.9 M
Slightly volatile
Common Stock95010003.1 K
Slightly volatile
Total Assets16.9 M17.7 M49 M
Slightly volatile
Cash5.9 M6.2 M40 M
Pretty Stable
Cash And Short Term Investments5.9 M6.2 M42.9 M
Slightly volatile
Liabilities And Stockholders Equity16.9 M17.7 M49 M
Slightly volatile
Total Current Assets10.8 M11.3 M44.3 M
Slightly volatile
Other Liabilities366 K310.5 K193.2 K
Slightly volatile
Property Plant And Equipment Net8.8 M4.8 M4.9 M
Slightly volatile
Net Receivables4.1 M3.9 M597.1 K
Slightly volatile
Other Current Assets1.7 M1.2 M983.7 K
Slightly volatile
Net Invested Capital116.8 K123 K57.7 M
Pretty Stable
Property Plant And Equipment Gross9.5 M9.3 M5.3 M
Slightly volatile
Capital Stock9501000K
Slightly volatile
Non Current Liabilities Other1.7 M2.2 M1.2 M
Slightly volatile
Long Term Debt Total9.7 M11 M11.9 M
Slightly volatile
Capital Lease Obligations2.8 M2.5 M2.3 M
Slightly volatile

Mustang Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General AdministrativeM9.7 M5.6 M
Slightly volatile
Research Development36.8 M39.2 M24.1 M
Slightly volatile
Total Operating Expenses45.5 M48.5 M29.6 M
Slightly volatile
Interest Income710.6 K1.1 M398.3 K
Slightly volatile
Other Operating Expenses50.8 M50.7 M32.6 M
Slightly volatile
Non Recurring8.4 M11.6 M7.7 M
Slightly volatile
Reconciled Depreciation1.9 M2.7 M912.6 K
Slightly volatile

Mustang Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock789.2 K830.7 K22.6 M
Slightly volatile
Depreciation1.4 M2.2 M849.9 K
Slightly volatile
Capital Expenditures108.3 K114 KM
Slightly volatile
Change To Netincome9.7 M12.7 M7.3 M
Slightly volatile
Other Non Cash Items2.3 M2.4 M7.5 M
Slightly volatile
Cash Flows Other Operating10.4 M18.2 M9.9 M
Slightly volatile
End Period Cash Flow5.9 M6.2 M40.4 M
Slightly volatile
Stock Based Compensation539.6 K568 K2.2 M
Very volatile
Begin Period Cash Flow67.2 M75.7 M45.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.03290.0370.0403
Slightly volatile
PTB Ratio99.1694.435318.8009
Slightly volatile
Book Value Per Share0.01360.014315.2301
Pretty Stable
PB Ratio99.1694.435318.8009
Slightly volatile
Payables Turnover0.340.35190.4564
Slightly volatile
Cash Per Share0.690.724516.6529
Pretty Stable
Capex To Operating Cash Flow0.00220.00230.1682
Slightly volatile
Days Payables Outstanding1.1 KK936
Slightly volatile
Income Quality0.540.95880.5212
Slightly volatile
Net Debt To EBITDA0.07320.0771.5711
Slightly volatile
Current Ratio0.70.73817.9022
Slightly volatile
Tangible Book Value Per Share0.01360.014315.2301
Pretty Stable
Graham Number1.321.388957.3388
Very volatile
Shareholders Equity Per Share0.01360.014315.2301
Pretty Stable
Interest Debt Per Share0.420.4431.4055
Pretty Stable
Debt To Assets0.0960.14080.0886
Slightly volatile
Price Book Value Ratio99.1694.435318.8009
Slightly volatile
Days Of Payables Outstanding1.1 KK936
Slightly volatile
Company Equity Multiplier15114420.7679
Slightly volatile
Long Term Debt To Capitalization0.990.94150.3
Slightly volatile
Quick Ratio0.630.65797.8225
Slightly volatile
Net Income Per E B T1.111.171.0453
Slightly volatile
Cash Ratio0.390.40567.0975
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.251.00231.1847
Slightly volatile
Price To Book Ratio99.1694.435318.8009
Slightly volatile
Capital Expenditure Coverage Ratio19.9719.028.4733
Slightly volatile
Debt Ratio0.0960.14080.0886
Slightly volatile
Price Fair Value99.1694.435318.8009
Slightly volatile

Mustang Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap11 M11.6 M207.3 M
Slightly volatile

Mustang Fundamental Market Drivers

Cash And Short Term Investments6.2 M

Mustang Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Mustang Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Mustang Bio income statement, its balance sheet, and the statement of cash flows. Mustang Bio investors use historical funamental indicators, such as Mustang Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mustang Bio investors may use each financial statement separately, they are all related. The changes in Mustang Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mustang Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mustang Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mustang Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue310.5 K326 K
Total Revenue 0.00  0.00 
Cost Of Revenue2.2 M1.3 M
Stock Based Compensation To Revenue 0.00  0.00 
Sales General And Administrative To Revenue 0.00  0.00 
Research And Ddevelopement To Revenue 0.00  0.00 
Capex To Revenue 0.00  0.00 
Revenue Per Share 0.00  0.00 
Ebit Per Revenue 0.00  0.00 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Mustang Stock analysis

When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stocks Directory
Find actively traded stocks across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.00)
Revenue Per Share
(0)
Return On Assets
(0.58)
Return On Equity
(2.22)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.